PROMOTION A ACNELAN
mesoestetic unveil their new range of treatments that provide multifactorial control for acne-prone skin
M
ESOESTETIC PHARMA GROUP is well known for its continuous investment in R&D+i, which enable it to
provide new and efficient solutions to meet patients’ needs, particularly through projects for preventing and treating dermatological conditions. As a result of this firm commitment, mesoestetic Pharma Group has conceived an innovative professional method for the topical treatment of acne-prone and seborrhoeic skin. A new and extended product line developed in collaboration with a leading group of dermatologists that participated in the selection of active substances, design and validation of application guidelines, and experimental evaluation of the formulations.
It has been a successful
joint project that guarantees the highest efficacy, safety and quality of the products.
It is the first line to emerge from this
promising initiative that will be renewed in the future to develop a full range of dermatological treatments.
A multifactorial approach Patients with acne have a clear unmet need. The hormonal origin and multifactorial aetiological causes of the condition hinder optimal control of its signs and symptoms. That is why a multifocal approach is considered essential to the success of the treatment. The new mesoestetic acne method combines a treatment exclusively for medical use to be applied at the consultation: acnelan, with a complete line of home maintenance products. At the heart of the product line
formulation, lies the innovative
m.acne complex™, a unique combination of active substances selected specifically for their complementary ability to address the numerous factors that affect acne-prone and seborrhoeic skins. The formula contains salicylic acid, mandelic acid and sodium lepargilate, which when combined with exclusive bexaretinyl complex have a unique, synergistic effect that allows deep cleansing and integral renewal of acne-prone and seborrhoeic skin. The result of its effects include:
5A-reductase inhibition: this reduces levels of the enzyme involved in the excess androgen that causes acne
Unblocking the pilosebaceous canal: encourages keratolysis of the skin’s abnormally thick corneocyte layer and unblocks skin pores
Decreases sebum production: reduces the secretory activity of sebaceous glands
Control of bacterial proliferation: inhibits growth and reproduction of the strains making up the skin flora, which may infect blocked pilosebaceous canals
Less redness and less epidermal swelling: soothes and reduces the intensity of the inflammatory process of acne outbreaks
Lightens post-acneic hyper- pigmentation: improving the appearance of skin affected by hyperpigmentation after an acne outbreak.
For more information, please visit
Multicenter study of efficacy and safety with 30 volunteers with acne-prone skin. The acnelan protocol is administered in consultation in combination with maintenance home care treatments. (A) before and (B) after 1 session with the combined treatment
56 August/September 2015 |
prime-journal.com
www.mesoestetic.com Visit Mesoestetic at EADV, Booth number 55
CNE SOLUTION BY MESOESTETIC
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64